1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Hee Young Ju: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate, Consolidation: Vincristine, Mecaptopurine, Intrathecal Methotrexate, Consolidation: Vincristine, Mecaptopurine, Cyclophosphamide, Cytarabine, L-asparaginase, Intrathecal Methotrexate - Lymphoblastic Leukemia in Children | Phase 2 | Recruiting | Hee Young Ju | 116 | 2024-03-05 | 2026-07-29 |
Asparaginase (1) · Cyclophosphamide (1) · Cytarabine (1) · Dexamethasone (1) · Doxorubicin (1) · Mercaptopurine (1) · Methotrexate (1)
South Korea (1)